Stem cells are a type ofcells with self renewal and multi directional differentiation. The research onstem cell therapy and regenerative medicine has become the most eye catchingfield in natural science and has begun to be applied to human disease treatment,tissue repair, and even health care.

XP Biomed provides comprehensive product and service support suitable for clinical systems for your stem cell research, including NutriStem for Sartorius' mesenchymal stem cells (hMSC) and pluripotent stem cells (hPSC/iPSC) Serum free culture medium (all obtained FDA DMF registration number), VivaCell recombinant pancreatic enzyme, VivaCell platelet lysate (scientific/clinical grade), Serum free cryopreservation solution for stem cells,MSC adipogenic, osteogenic, and chondrogenic induction differentiation reagents and staining reagents, VivaCell primary MSC cell isolation solution, Clinical grade human recombinant laminin from BioLamina, Sweden, The Well brand provides VitroGel hydrogel for stem cell 3D culture and organoidresearch. Dr. Cell provides stem cellkaryotype analysis services and STR identification.

Stem cells, as pluripotent biological cell resources, demonstrate significant clinical potential in regenerative medicine. Through critical technical processes including in vitro isolation, purification, and expansion, combined with targeted differentiation induction protocols, researchers can cultivate novel, functionally competent, and rejuvenated cell populations under controlled conditions. These engineered cell populations, when reintroduced into the human body, achieve therapeutic objectives encompassing tissue regeneration, chronic disease management, and aging modulation.

The current manufacturing standards for clinical-grade stem cell-based therapeutics emphasize well-defined culture systems as essential quality criteria. With technological advancements, traditional culture matrices containing animal-derived components are being systematically replaced by xeno-free alternatives.